SYNOPSIS A method of investigating the coagulation mechanism is described.
Investigation of the coagulation mechanism is most reliably carried out on blood obtained rapidly from a clean venepuncture. In small infants and some older subjects, however, such specimens may be difficult to obtain; in such cases, free-flowing capillary blood is preferable to a venous sample obtained with difficulty through a small needle, in which contamination with tissue fluid and delay in taking are likely to result in early changes of coagulation before citrate is added. In this paper we describe a procedure by which a routine investigation of the blood coagulation mechanism can be carried out on 0-2 ml. of capillary blood; the results are compared with those obtained on venous blood taken from the same subjects simultaneously.
of samples from patients suspected of having a coagulation disorder, we have chosen to use a modification of the thromboplastin screening test of Hicks and Pitney (1957) as a test of blood thromboplastin formation, and the prothrombin and proconvertin (P and P) test of Owren and Aas (1951) as a test of the extrinsic coagulation system. This combination of tests will detect deficiencies of all known clotting factors except fibrinogen, as shown in Table I . As a simple test to exclude serious fibrinogen deficiency, the clotting time test of Dale and Laidlaw (1911) may be carried out on the capillary blood sample. If the screening procedures mentioned above reveal a defect, more specific tests may be carried out on the same sample; in this way, the exact nature of the clotting defect may be identified and its degree determined by means of quantitative assay procedures. This paper, however, is concerned with screening procedures only, and the details of specific assay methods will not be considered.
METHODS
SUBJECTS STUDIED Capillary blood and venous blood were collected as described below from normal adults and from patients of various ages with haemophilia, Christmas disease, or congenital deficiency of factor V, factor VII, or plasma thromboplastin antecedent (PTA). Blood was also taken from a series of adults on long-term anticoagulant therapy with phenindione (Dindevan) and from patients with acquired 'hypoprothrombinaemia' from various causes, particularly liver disease. (Owren, 1949 Of this fluid 0-2 ml. is then drawn up from the polythene tube into a pipette calibrated to contain 0-2 and 0-4 ml. A well-warmed finger (or heel in the case of an infant) is stabbed with a sharp Hagedorn needle, and, after wiping away the first drop, blood is drawn up under the fluid in the pipette until the total volume is 0 4 ml. The whole is then washed out into the remainder of the fluid in the polythene tube, which thus contains 2-0 ml. of a 1 in 10 dilution of whole blood in buffered citrate-saline. Two heparinized microhaematocrit tubes are then filled from the same stab wound. The whole collection should not take more than one minute.
The dilute blood is centrifuged at 2,500 r.p.m. for 15 minutes, and the supernatant used in the tests described below. The subject's packed-cell volume (P.C.V.) is determined by the use of a microhaematocrit centrifuge, and used to calculate the actual dilution of the plasma tested (see below). Owren and Aas (1951) as modified by Biggs and Macfarlane (1957) . Capillary plasma was tested after removal of the red cells by centrifugation as described above, but without further dilution. Barbitone buffer, pH (Owren, 1949 The same final concentrations of citrate, NaCl, and buffer were thus obtained in the test dilutions of both venous and capillary plasma.
The clotting times in this system of the test plasmas were determined in duplicate in each case, and the mean clotting times converted to percentages of normal 'P and P' activity by interpolation on a standard dilution curve prepared from pooled normal venous plasma. In order that the results obtained on capillary and venous blood might be directly compared, the percentage activity of a 1 in 10 plasma dilution was calculated in each case by correcting the observed activity for the diluting effect of the anticoagulant, which varies with the P.C.V.; the calculations involved may be reduced to the following formulae:
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where Pc and Pv are the P and P percentage activities respectively of the capillary and venous plasma dilutions tested. In practice, it is always necessary to correct capillary plasma results in this way, as differences in P.C.V. have a significant effect on the finalplasma dilution. In all the other cases of haemophilia investigated, antihaemophilic factor assays were performed on venous samples by a modification of the thromboplastin generation test similar to that described by Pitney (1956) , in which the ability of the patient's Al(OH)3-adsorbed plasma to correct the defect of Al(OH)3-adsorbed plasma from a severe haemophiliac was compared with that of AI(OH)3-adsorbed pooled normal plasma.
CHRISTMAS FACTOR ASSAYS In each of the seven patients with Christmas disease studied, the diagnosis was based on the result of a thromboplastin generation test, and the level of Christmas factor was determined by a one-stage method in which the correction of the kaolin clotting time of Christmas-factor-deficient plasma by serial dilutions of patient's plasma was measured.
RESULTS

EFFECT OF DELAY IN COLLECTING CAPILLARY BLOOD
It was thought that a likely source of error in results obtained in capillary blood would be delay in the collection of blood after pricking the finger; this might allow some of the early changes of coagulation to occur at the site of injury before the sample was obtained. In order to determine the importance of speed of collection, three separate capillary blood samples were taken consecutively from the same fingerprick in a small series of subjects, and thromboplastin screening tests and 'P and P' determinations were carried out in parallel on all three specimens. The time taken to collect each specimen varied between 20 and 60 seconds, and the whole collection was completed in each case within three minutes.
It was found that there was no significant difference in 'P and P' results between any of the three specimens nor between the first two specimens in the results of the thromboplastin screening test; in this test, however, the clotting times obtained with Table II . These findings indicate the importance of rapid collection of capillary blood samples, and suggest that specimens collected within one minute will give reliable results in practice.
PROTHROMBIN AND PROCONVERTIN (P AND P) TEST The P and P test was performed on samples of venous and capillary plasma obtained simultaneously from 21 normal subjects, 40 patients receiving anticoagulant treatment with phenindione, and 10 patients with various congenital clotting defects. The results, corrected for dilution, are plotted in Fig. 1 , from which it can be seen that there is good correlation between the capillary and venous results, particularly in the 0 to 60% range. THROMBOPLASTIN SCREENING TEST Thromboplastin screening tests were carried out on a total of 29 capillary blood samples from patients with haemophilia and Christmas disease of various degrees of clinical severity, in whom antihaemophilic factor or Christmas factor assays were also performed. In eight instances, the antihaemophilic factor or Christmas factor had been raised to values between 15 and 50% by replacement therapy. In Fig. 2 , the shortest second-stage clotting times obtained in the thromboplastin screening test are plotted against the antihaemophilic factor and Christmas factor levels; the screening test times were outside the normal control range in every case in which the antihaemophilic factor or Christmas factor was below 35%, and tended to be longest in the cases with the lowest levels of antihaemophilic factor or Christmas factor. In Figs. 3 to 5 are shown the results of 'P and P' and thromboplastin screening tests carried out on capillary blood samples from patients with 'hypoprothrombinaemia' resulting from vitamin K deficiency and with congenital deficiencies of factor V and factor VII respectively. These examples illustrate the three patterns of abnormality detectable by the use of these two tests (cf. Table I ).
Many children have been investigated by these methods before operation, on account of a history suggestive of a bleeding tendency. Whenever the shortest clotting time in the thromboplastin screening test exceeded that of the normal control by three seconds or more, or the 'P and P' level was below 50 %, further investigation of the coagulation mechanism was carried out. All other patients were regarded as suitable for operation provided that the platelet count and bleeding time were also normal, and none of these bled excessively. 
DISCUSSION
The main theoretical objections to the use of capillary blood for tests of the coagulation mechanism concern the difficulty of obtaining a large enough volume of blood before the early changes of coagulation have occurred; this difficulty is aggravated by the likelihood of contamination of the sample with tissue fluid. The method described here, in which a very small volume of blood is taken directly into anticoagulant, largely overcomes this obstacle by ensuring rapid collection; the reliability of the method is shown by the fact that two consecutive samples could always be obtained in this way without significant change in clotting activity.
Somewhat similar methods of collection have been used by other workers to obtain blood for prothrombin time estimations (Dyggve and Lund 1954; Miale and Winningham, 1960) , but those who have attempted more extensive studies of the coagulation process on capillary blood have usually taken larger volumes. Ashley (1958) , for example, took 0-9 ml. of capillary blood into 0. 1 ml. citrate from a small series of normal subjects and obtained results in a battery of coagulation tests which were comparable with those of similar tests on venous blood from the same subjects; he showed no direct evidence, however, of the reliability of his procedure as a means of detecting coagulation defects.
The 
